Open in Screener

JNJ

Johnson & Johnson

Feb 20 • 04:00PM ET

242.49

-4.42 -1.79 %

Healthcare • Drug Manufacturers - General • USA • NYSE

Today, 8:05 AMJohnson & Johnson reports 3-year QUASAR data showing TREMFYA sustains high remission and mucosal healing in adults with moderate to severe ulcerative colitis

Peers: MRK PFE NVS AMGN BMY LLY GSK ABT MDT SYK

| Held by: VTI VOO IVV SPY VTV XLV VIG VYM VHT DIA

Index	DJIA, S&P 500	P/E	21.95	EPS (ttm)	11.05	Insider Own	0.13%	Shs Outstand	2.41B	Perf Week	-0.84%
Market Cap	584.38B	Forward P/E	19.33	EPS next Y	12.54	Insider Trans	-14.64%	Shs Float	2.41B	Perf Month	11.23%
Enterprise Value	613.61B	PEG	2.33	EPS next Q	2.69	Inst Own	75.99%	Short Float	0.81%	Perf Quarter	21.25%
Income	26.80B	P/S	6.20	EPS this Y	7.18%	Inst Trans	0.01%	Short Ratio	2.18	Perf Half Y	35.59%
Sales	94.19B	P/B	7.16	EPS next Y	8.46%	ROA	14.13%	Short Interest	19.56M	Perf YTD	17.17%
Book/sh	33.86	P/C	29.07	EPS next 5Y	8.28%	ROE	35.03%	52W High	246.96 -1.81%	Perf Year	51.86%
Cash/sh	8.34	P/FCF	29.67	EPS past 3/5Y	17.88% 14.90%	ROIC	21.90%	52W Low	141.50 71.37%	Perf 3Y	51.19%
Dividend Est.	5.31 (2.19%)	EV/EBITDA	18.52	Sales past 3/5Y	5.56% 2.67%	Gross Margin	67.97%	Volatility	1.36% 1.54%	Perf 5Y	48.79%
Dividend TTM	5.14 (2.12%)	EV/Sales	6.51	EPS Y/Y TTM	90.55%	Oper. Margin	27.21%	ATR (14)	3.79	Perf 10Y	132.81%
Dividend Ex-Date	Feb 24, 2026	Quick Ratio	0.77	Sales Y/Y TTM	6.05%	Profit Margin	28.46%	RSI (14)	70.35	Recom	2.11
Dividend Gr. 3/5Y	4.92% 5.25%	Current Ratio	1.03	EPS Q/Q	48.39%	SMA20	3.01%	Beta	0.33	Target Price	238.78
Payout	46.59%	Debt/Eq	0.60	Sales Q/Q	9.07%	SMA50	10.19%	Rel Volume	1.50	Prev Close	246.91
Employees	140800	LT Debt/Eq	0.50	Earnings	Jan 21 BMO	SMA200	30.64%	Avg Volume	8.99M	Price	242.49
IPO	Sep 25, 1944	Option/Short	Yes / Yes	EPS/Sales Surpr.	-0.12% 1.72%	Trades		Volume	13,520,556	Change	-1.79%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-28-26	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$262
Nov-13-25	Initiated	Scotiabank	Sector Outperform	$230
Oct-20-25	Upgrade	Daiwa Securities	Neutral → Outperform	$203
Oct-03-25	Upgrade	Wells Fargo	Equal Weight → Overweight	$212
Sep-23-25	Upgrade	Guggenheim	Neutral → Buy	$206
Jul-23-25	Upgrade	Erste Group	Hold → Buy
May-13-25	Downgrade	Leerink Partners	Outperform → Market Perform	$153
Dec-10-24	Resumed	BofA Securities	Neutral	$166
Nov-15-24	Initiated	Wolfe Research	Outperform	$190
Jul-23-24	Downgrade	Daiwa Securities	Outperform → Neutral	$160 → $150
May-30-24	Resumed	Goldman	Neutral	$160
Apr-18-24	Upgrade	HSBC Securities	Hold → Buy	$170
Dec-13-23	Downgrade	Wells Fargo	Overweight → Equal Weight	$170 → $163
Dec-01-23	Upgrade	UBS	Neutral → Buy	$167 → $180
Oct-05-23	Initiated	RBC Capital Mkts	Outperform	$178
Sep-06-23	Initiated	HSBC Securities	Hold	$175
May-30-23	Resumed	Citigroup	Buy	$185
Mar-29-23	Initiated	UBS	Neutral	$164
Mar-01-23	Initiated	Guggenheim	Neutral	$161
Nov-18-22	Initiated	Credit Suisse	Neutral	$170

Show Previous Ratings

Today 08:00AM	TREMFYA (guselkumab) long-term data show sustained clinical and endoscopic remission in ulcerative colitis through 3 years (PR Newswire)
Feb-20-26 11:30AM	Why Is Johnson & Johnson (JNJ) Up 13% Since Last Earnings Report? (Zacks)
10:01AM	Johnson & Johnson Prepares Potential $20 Billion+ DePuy Sale (GuruFocus.com)
10:00AM	Johnson & Johnson Eyes Medtech Divestiture (GuruFocus.com)
08:16AM	Will Immunology Drugs Continue to Drive AbbVie's Top Line in 2026? (Zacks)
07:47AM	Loading…
07:47AM	American Express, Deere Drop Board Diversity Criteria as 78% Disclosure Rate Falls (GuruFocus.com)
06:53AM	J&J Eyes Mega Sale Of DePuy Synthes In Orthopedics Breakup Push (Benzinga)
05:23AM	Madrigal sees a stock sell-off; ex-Novartis exec heads to Daiichi (BioPharma Dive)
Feb-19-26 06:30PM	Corporate giants retreat from board diversity mandates, Bloomberg reports (Investing.com)
05:00PM	RYBREVANT FASPRO (amivantamab and hyaluronidase-lpuj) plus immunotherapy shows strong clinical benefit with 56 percent overall response rate in first-line recurrent or metastatic head and neck cancer (PR Newswire)
02:49PM	Johnson & Johnson explores $20 billion sale of orthopedics unit, Bloomberg News reports (Reuters)
02:16PM	J&J Explores $20 Billion-Plus Sale of Orthopedics Unit (Bloomberg)
01:34PM	Johnson & Johnson to invest $1B in Pennsylvania manufacturing facility (Fox Business)
10:15AM	Pfizer Targets Long-Term Oncology Growth Amid Competitive Pressure (Zacks)
07:02AM	J&J to build $1bn US CGT manufacturing site in Pennsylvania (Pharmaceutical Technology)
11:17AM	Loading…
Feb-18-26 11:17AM	Halozyme's Q4 Earnings Miss, Higher Royalties Drive Y/Y Revenues (Zacks)
10:44AM	Johnson & Johnson to Invest More Than $1 Billion in Pennsylvania Cell Therapy Factory (The Wall Street Journal)
10:15AM	Johnson & Johnson Expands U.S. Footprint with more than $1 Billion Investment in Next Generation Cell Therapy Manufacturing Facility in Pennsylvania (Business Wire)
10:10AM	FDA Grants Breakthrough Status To Johnson & Johnson's Cancer Drug For Advanced Head and Neck Cancer (Benzinga)
09:15AM	Verizon vs Johnson & Johnson: Which Dividend Hike Winner Is the Better Buy? (24/7 Wall St.)
09:00AM	Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
07:30AM	RYBREVANT FASPRO (amivantamab and hyaluronidase-lpuj) receives U.S. FDA Breakthrough Therapy Designation for patients with advanced head and neck cancer (PR Newswire)
05:32AM	XLV is A $41 Billion Defensive Healthcare Play That Looks Good Until You Compare To The S&P 500 (24/7 Wall St.)
Feb-17-26 09:21PM	This State Has More Millionaires Per Capita Than Any Other (24/7 Wall St.)
04:30PM	Jury: Johnson & Johnson Liabile in Case Linking Baby Powder to Cancer (Benzinga)
02:32PM	Neumora Therapeutics Stock Jumps, Analyst Sees Upside In Alzheimer's Treatment (Benzinga)
01:26PM	This auto-parts maker is jumping on the breakup bandwagon. Here's why the stock is tanking. (MarketWatch)
11:45AM	Johnson & Johnson's New FDA Approval Lets Lung Cancer Patients Switch To Monthly Dosing Sooner (Benzinga)
09:27AM	Beat the Market the Zacks Way: Micron Technology, Cooper Companies, Coeur Mining in Focus (Zacks)
08:57AM	AbbVie Down Since Q4 Earnings Report: How to Play the Stock (Zacks)
08:00AM	Loading…
08:00AM	FDA approves RYBREVANT FASPRO (amivantamab and hyaluronidase-lpuj) as the only EGFR-targeted therapy that can be administered once a month (PR Newswire)
Feb-16-26 09:55AM	J&J's MedTech Shows Strong Growth in 2025: Will 2026 be Better? (Zacks)
Feb-14-26 03:41PM	Jury: Johnson & Johnson Liabile in Case Linking Baby Powder to Cancer (Benzinga)
02:04PM	Oric Pharmaceuticals Highlights 2025 Milestones at Guggenheim, Targets Phase 3 Prostate Trial in 1H25 (MarketBeat)
12:44PM	Johnson & Johnson (JNJ) Is Amazing, Says Jim Cramer (Insider Monkey)
Feb-13-26 04:18PM	Philadelphia Jury Returns $250,000 Verdict Against J&J in Latest Baby Powder-Ovarian Cancer Trial (Business Wire)
02:48PM	Pennsylvania jury finds Johnson & Johnson liable for cancer in latest talc trial (Reuters)
10:09AM	Johnson & Johnson (JNJ) Reports 100% Success in OMNY-AF Study (Insider Monkey)
09:57AM	Why is Johnson & Johnson (JNJ) One of the Best Medical Research Stocks to Buy According to Hedge Funds? (Insider Monkey)
Feb-12-26 01:25PM	Pentair Just Paid Out: Is This Industrial Dividend Built to Last? (24/7 Wall St.)
01:04PM	Abbott Labs Just Extended Its Dividend Aristocrat Status: What Comes Next? (24/7 Wall St.)
05:02AM	enGene CEO Talks Detalimogene for Community Urology as LEGEND Study Hits Full Enrollment (MarketBeat)
Feb-11-26 02:23PM	NIH Stops Johnson & Johnson's Blood Thinner Drug Arm In Stroke Trial After Safety Review (Benzinga)
11:14AM	Should You Buy ISRG Stock Despite a 13% Fall in Three Months? (Zacks)
08:23AM	VYMs S&P Beating Dividend Survived Two Decades Without Missing a Payment (24/7 Wall St.)
08:09AM	Can Pfizer's New & Acquired Drugs Offset Its Looming Patent Cliff? (Zacks)
07:48AM	JEPIs 8% Yield Is Impressive, But Has a Hidden Cost Most Retirees Miss (24/7 Wall St.)
Feb-10-26 04:51PM	Gilead Earnings Surprise. Why The Stock Is Tumbling Anyway. (Barrons.com)
08:32AM	Here's What Will Drive AbbVie's Top-line Growth in 2026 (Zacks)
08:30AM	Novel Serotonergic Agonists Positioned to Capture Share of $150B+ Neuropsychiatric Market (PR Newswire)
05:53AM	4 takeaways from the 2026 AF Symposium (MedTech Dive)
Feb-09-26 04:16PM	Johnson & Johnson to Participate in the Barclays 28th Annual Global Healthcare Conference (Business Wire)
03:13PM	Eli Lilly to Buy Cell Therapy Company Orna for $2.4 Billion (Barrons.com)
11:45AM	Why Johnson & Johnson (JNJ) is a Great Dividend Stock Right Now (Zacks)
10:46AM	5 Stocks and ETFs to Help Shield Your Portfolio During Volatility (MarketBeat)
10:00AM	Eli Lilly Stock Rises. Its Acquiring This Cell Therapy Company for $2.4 Billion. (Barrons.com)
09:53AM	Dow Jones' revolving door: What happened to 5 companies after they were dropped from the DJIA (TheStreet)
09:24AM	J&J Posts Innovative Medicine Growth in 2025 Amid Stelara Patent Loss (Zacks)
08:51AM	Banking on Yield? Heres How We Scored Dime Community Bancshares (DCOM) Dividend (24/7 Wall St.)
07:25AM	Johnson & Johnson Reports 90% AFib Freedom In Early Heart Device Study (Benzinga)
04:27AM	Can reshoring deliver manufacturing sustainability benefits? (Manufacturing Dive)
Feb-08-26 12:25PM	IVVs Uninterrupted Dividend Streak Since 2000 Masks The True Income Profile (24/7 Wall St.)
Feb-07-26 10:06PM	Recession-proof Dividend King offers safe 2.2% yield (TheStreet)
12:56AM	Jim Cramer Says Stocks Like Johnson & Johnson "Simply Refuse to Quit" (Insider Monkey)
Feb-06-26 11:04AM	Merck's Subdued 2026 Outlook: What it Means After Q4 Results? (Zacks)
10:50AM	Johnson & Johnson Is a Resilient Blue-Chip Stock and It Just Hit New All-Time Highs (Barchart)
10:46AM	Bayer's Asundexian Shows 26% Stroke Reduction in Late-Stage Study (Zacks)
09:28AM	Low Volatility ETFs to Watch Amid Major Tech Sell-Off Over AI Panic (Zacks)
09:00AM	Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Feb-05-26 02:42PM	RBC Sees Johnson & Johnson (JNJ) Well Positioned to Manage Legal Overhang (Insider Monkey)
11:14AM	Why Mid Cap Dividend Stocks Are Gaining an Edge Over Large Caps This Year (24/7 Wall St.)
09:55AM	This Medical Technology Leader Sees Growth Into The 2040s (Investor's Business Daily)
03:00AM	Big Pharma CEOs set sights on massive growth in years to come (Pharma Voice)
Feb-04-26 04:47PM	Nearly 20% of S&P 500 Stocks Hit 52-Week Highs Today (The Wall Street Journal)
01:45PM	Dozens of Stocks Hitting 52-Week Highs (The Wall Street Journal)
12:28PM	AbbVie Beats on Q4 Earnings, Stock Down Despite Upbeat '26 View (Zacks)
11:25AM	Johnson & Johnson's Getting Back to Double-Digit Growth. Has the Stock Become a Bargain Buy? (Motley Fool)
10:55AM	The John Bogle Method for Building a Dividend Portfolio Under $10,000 (24/7 Wall St.)
08:31AM	GSK's Q4 Earnings & Sales Beat Estimates, Stock Up on '26 Outlook (Zacks)
Feb-03-26 08:21PM	Analyst Report: Johnson & Johnson (Morningstar Research)
11:39AM	Will Reblozyl Shine in Bristol Myers' Fourth-Quarter Results? (Zacks)
04:34AM	BofA Lifts PT on Johnson & Johnson (JNJ) to $227 From $221 - Here's Why (Insider Monkey)
Feb-02-26 04:34PM	Johnson & Johnson to Participate in the TD Cowen 46th Annual Health Care Conference (Business Wire)
11:40AM	Merck Reports Earnings Tuesday Morning After Gaining 13% Over the Past Year (24/7 Wall St.)
10:34AM	Buy AbbVie Stock Before Q4 Earnings? Here's What to Know (Zacks)
09:51AM	Morgan Stanley Upgrades Johnson & Johnson to Overweight, Increases PT to $262 (Insider Monkey)
Jan-31-26 07:35PM	Looking for Passive Income in 2026? 3 Dividend Kings to Buy Hand Over Fist (Motley Fool)
12:35PM	Is Johnson & Johnson (JNJ) The Most Profitable Healthcare Stock To Buy? (Insider Monkey)
Jan-30-26 10:38PM	This Top Dividend Stock Could Achieve a Major Milestone This Year. Is It a Buy? (Motley Fool)
08:28AM	What Are Wall Street Analysts' Target Price for Johnson & Johnson Stock? (Barchart)
Jan-29-26 06:32PM	US judge tosses lawsuit accusing J&J of fraud over talc bankruptcy strategy (Reuters)
04:06PM	1 Dividend King to Buy and Hold Through Any Market (Barchart)
12:45PM	Scotiabank Raises Johnson & Johnson (JNJ) Target on Strong Quarterly Results (Insider Monkey)
12:42PM	This Winning Fund Pro Likes J&J, Lowe's, and Utility Stocks (Barrons.com)
11:52AM	HALO Rises Nearly 4% on Strong 2025 Preliminary Data and 2026 Guidance (Zacks)
09:41AM	PayPal downgraded, UPS upgraded: Wall Streets top analyst calls (TipRanks)
09:13AM	Healthcare ETFs in Focus as UnitedHealth Rises 4% Post Mixed Q4 Results (Zacks)
07:12AM	Johnson & Johnson Stock Rises After Morgan Stanley Upgrade (GuruFocus.com)
03:55AM	The Zacks Analyst Blog Johnson & Johnson, Netflix, Arista Networks, Omega and AXIL (Zacks)
Jan-28-26 05:02PM	Top Stock Reports for Johnson & Johnson, Netflix & Arista Networks (Zacks)

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Schmid Timothy	Officer	Feb 20 '26	Proposed Sale	245.66	1,322	324,763		Feb 20 10:46 AM
Swanson James D.	EVP, CIO	Feb 13 '26	Option Exercise	132.73	51,418	6,824,543	47,211	Feb 18 09:12 PM
Swanson James D.	EVP, CIO	Feb 17 '26	Option Exercise	164.62	20,521	3,378,167	46,219	Feb 18 09:12 PM
Swanson James D.	EVP, CIO	Feb 15 '26	Option Exercise	0.00	1,201	0	26,007	Feb 18 09:12 PM
Swanson James D.	EVP, CIO	Feb 13 '26	Sale	243.73	41,559	10,129,312	25,020	Feb 18 09:12 PM
Swanson James D.	EVP, CIO	Feb 17 '26	Sale	242.70	20,521	4,980,447	25,698	Feb 18 09:12 PM
Wengel Kathryn E	EVP, Chief TO and Risk Officer	Feb 15 '26	Option Exercise	0.00	1,241	0	114,613	Feb 18 09:12 PM
Wengel Kathryn E	EVP, Chief TO and Risk Officer	Feb 13 '26	Option Exercise	0.00	14,357	0	120,096	Feb 18 09:12 PM
Mulholland Kristen	EVP, Chief HR Officer	Feb 15 '26	Option Exercise	0.00	994	0	20,081	Feb 18 09:12 PM
Mulholland Kristen	EVP, Chief HR Officer	Feb 13 '26	Option Exercise	0.00	4,012	0	20,286	Feb 18 09:12 PM
Wolk Joseph J	Exec VP, CFO	Feb 17 '26	Option Exercise	126.65	64,693	8,193,223	72,347	Feb 18 09:12 PM
Wolk Joseph J	Exec VP, CFO	Feb 15 '26	Option Exercise	0.00	3,849	0	39,778	Feb 18 09:12 PM
Wolk Joseph J	Exec VP, CFO	Feb 13 '26	Option Exercise	0.00	39,242	0	51,463	Feb 18 09:12 PM
Wolk Joseph J	Exec VP, CFO	Feb 17 '26	Sale	242.80	89,654	21,767,827	14,000	Feb 18 09:12 PM
Decker Robert J	VP Corporate Controller	Feb 15 '26	Option Exercise	0.00	683	0	23,777	Feb 18 09:12 PM
Decker Robert J	VP Corporate Controller	Feb 13 '26	Option Exercise	0.00	3,053	0	23,950	Feb 18 09:12 PM
REED JOHN C	EVP, Innovative Medicine, R&D	Feb 17 '26	Option Exercise	156.89	51,648	8,103,281	42,868	Feb 18 09:12 PM
REED JOHN C	EVP, Innovative Medicine, R&D	Feb 15 '26	Option Exercise	0.00	3,196	0	13,469	Feb 18 09:12 PM
REED JOHN C	EVP, Innovative Medicine, R&D	Feb 17 '26	Sale	243.00	53,931	13,105,233	10,658	Feb 18 09:12 PM
Forminard Elizabeth	EVP, Chief Legal Officer	Feb 15 '26	Option Exercise	0.00	2,024	0	24,112	Feb 18 09:11 PM
Forminard Elizabeth	EVP, Chief Legal Officer	Feb 13 '26	Option Exercise	0.00	14,357	0	29,591	Feb 18 09:11 PM
Taubert Jennifer L	EVP, WWC. Innovative Medicine	Feb 15 '26	Option Exercise	0.00	3,441	0	195,396	Feb 18 09:11 PM
Taubert Jennifer L	EVP, WWC. Innovative Medicine	Feb 13 '26	Option Exercise	0.00	28,714	0	206,318	Feb 18 09:11 PM
Schmid Timothy	EVP, WW Chair, MedTech	Feb 18 '26	Option Exercise	121.17	22,623	2,741,335	40,394	Feb 18 09:11 PM
Schmid Timothy	EVP, WW Chair, MedTech	Feb 15 '26	Option Exercise	0.00	2,054	0	27,217	Feb 18 09:11 PM
Schmid Timothy	EVP, WW Chair, MedTech	Feb 13 '26	Option Exercise	0.00	4,877	0	26,994	Feb 18 09:11 PM
Schmid Timothy	EVP, WW Chair, MedTech	Feb 18 '26	Sale	244.33	22,623	5,527,506	26,769	Feb 18 09:11 PM
Duato Joaquin	CEO and Chairman of the Board	Feb 15 '26	Option Exercise	0.00	8,187	0	326,407	Feb 18 09:11 PM
Duato Joaquin	CEO and Chairman of the Board	Feb 13 '26	Option Exercise	0.00	76,523	0	351,501	Feb 18 09:11 PM
Broadhurst Vanessa	EVP, Global Corp Affairs	Feb 15 '26	Option Exercise	0.00	1,018	0	29,470	Feb 18 09:11 PM
Broadhurst Vanessa	EVP, Global Corp Affairs	Feb 13 '26	Option Exercise	0.00	9,002	0	32,452	Feb 18 09:11 PM
Broadhurst Vanessa	EVP, Global Corp Affairs	Feb 17 '26	Sale	243.39	6,197	1,508,288	23,003	Feb 18 09:11 PM
Schmid Timothy	Officer	Feb 18 '26	Proposed Sale	244.33	22,623	5,527,546		Feb 18 11:14 AM
Broadhurst Vanessa	Officer	Feb 17 '26	Proposed Sale	243.39	6,197	1,508,300		Feb 17 04:10 PM
Swanson James D.	Officer	Feb 17 '26	Proposed Sale	242.70	20,521	4,980,510		Feb 17 02:52 PM
Wolk Joseph J	Officer	Feb 17 '26	Proposed Sale	242.80	89,654	21,767,965		Feb 17 02:43 PM
REED JOHN C	Officer	Feb 17 '26	Proposed Sale	243.00	53,931	13,105,233		Feb 17 12:44 PM
Swanson James D.	Officer	Feb 13 '26	Proposed Sale	243.73	41,559	10,129,246		Feb 13 02:33 PM
Schmid Timothy	EVP, WW Chair, MedTech	Feb 06 '26	Option Exercise	101.87	15,571	1,586,218	32,460	Feb 10 09:46 PM
Mulholland Kristen	EVP, Chief HR Officer	Feb 06 '26	Option Exercise	101.87	5,625	573,019	19,744	Feb 09 07:42 PM
Wengel Kathryn E	EVP, Chief TO and Risk Officer	Feb 06 '26	Option Exercise	101.87	38,945	3,967,327	133,226	Feb 09 07:40 PM
Forminard Elizabeth	EVP, Chief Legal Officer	Feb 05 '26	Option Exercise	129.51	8,921	1,155,359	21,774	Feb 06 05:46 PM
Forminard Elizabeth	Officer	Feb 05 '26	Proposed Sale	237.90	6,226	1,481,195		Feb 05 04:31 PM
Duato Joaquin	CEO and Chairman of the Board	Jan 26 '26	Sale	221.23	100,000	22,122,893	30,852	Jan 28 06:07 PM
Joaquin Duato	CEO, Chariman	Jan 26 '26	Proposed Sale	220.14	100,000	22,014,000		Jan 26 04:57 PM
MORIKIS JOHN G	Director	Nov 26 '25	Buy	206.15	1,250	257,688	1,849	Dec 01 04:15 PM
JOHNSON & JOHNSON	10% Owner	Nov 26 '25	Sale	10.03	6,337	63,560	4,040,861	Dec 01 04:07 PM
JOHNSON & JOHNSON	10% Owner	Nov 24 '25	Sale	10.06	2,200	22,132	4,047,198	Nov 25 12:54 PM
JOHNSON & JOHNSON	10% Owner	Nov 21 '25	Sale	10.00	500	5,000	4,049,398	Nov 25 12:54 PM
JOHNSON & JOHNSON	10% Owner	Nov 12 '25	Sale	10.00	1,000	10,000	4,049,898	Nov 14 03:07 PM
JOHNSON & JOHNSON	10% Owner	Nov 06 '25	Sale	10.21	52,332	534,310	4,051,098	Nov 10 03:28 PM
JOHNSON & JOHNSON	10% Owner	Nov 07 '25	Sale	10.00	200	2,000	4,050,898	Nov 10 03:28 PM
REED JOHN C	EVP, Innovative Medicine, R&D	Oct 17 '25	Option Exercise	157.92	21,721	3,430,180	32,379	Oct 20 07:13 PM
REED JOHN C	EVP, Innovative Medicine, R&D	Oct 17 '25	Sale	192.71	21,721	4,185,793	10,658	Oct 20 07:13 PM
REED JOHN C	Officer	Oct 17 '25	Proposed Sale	192.71	21,721	4,185,794		Oct 17 10:23 AM
Taubert Jennifer L	EVP, WWC. Innovative Medicine	Sep 04 '25	Option Exercise	101.87	56,471	5,752,701	234,484	Sep 05 06:00 PM
Taubert Jennifer L	EVP, WWC. Innovative Medicine	Sep 04 '25	Sale	177.81	56,471	10,040,883	178,013	Sep 05 06:00 PM
Taubert Jennifer L	Officer	Sep 04 '25	Proposed Sale	177.81	56,471	10,040,904		Sep 04 02:37 PM
Forminard Elizabeth	Executive VP, General Counsel	Aug 29 '25	Option Exercise	115.67	11,521	1,332,634	22,423	Sep 03 05:13 PM
Forminard Elizabeth	Officer	Aug 29 '25	Proposed Sale	177.20	9,570	1,695,806		Aug 29 03:36 PM
Duato Joaquin	CEO and Chairman of the Board	Aug 22 '25	Option Exercise	101.87	125,824	12,817,691	401,791	Aug 25 07:12 PM
Duato Joaquin	CEO and Chairman of the Board	Aug 22 '25	Sale	179.21	125,824	22,548,655	275,967	Aug 25 07:12 PM
Duato Joaquin	Officer	Aug 22 '25	Proposed Sale	180.03	125,824	22,652,724		Aug 22 01:58 PM
Wolk Joseph J	Exec VP, CFO	Aug 15 '25	Option Exercise	101.87	16,820	1,713,453	30,820	Aug 18 06:19 PM
Wolk Joseph J	Exec VP, CFO	Aug 15 '25	Sale	176.91	16,820	2,975,571	14,000	Aug 18 06:19 PM
Wolk Joseph J	Officer	Aug 15 '25	Proposed Sale	176.91	16,820	2,975,571		Aug 15 03:57 PM
REED JOHN C	EVP, Innovative Medicine, R&D	Jul 17 '25	Sale	163.55	19,137	3,129,830	10,658	Jul 18 04:12 PM
REED JOHN C	Officer	Jul 17 '25	Proposed Sale	163.55	19,137	3,129,831		Jul 17 04:05 PM
REED JOHN C	EVP, Innovative Medicine, R&D	May 01 '25	Option Exercise	0.00	25,255	0	40,797	May 05 05:10 PM
Decker Robert J	VP Corporate Controller	Feb 25 '25	Option Exercise	101.87	6,999	712,988	28,000	Feb 26 06:42 PM
Decker Robert J	VP Corporate Controller	Feb 25 '25	Sale	165.88	6,999	1,160,994	21,001	Feb 26 06:42 PM
Decker Robert J	Officer	Feb 25 '25	Proposed Sale	165.88	6,999	1,161,010		Feb 25 03:05 PM

Open in Screener

PRU

Prudential Financial Inc

Feb 20 • 04:00PM ET

103.44

+0.73 0.71 %

Financial • Insurance - Life • USA • NYSE

PRU Prudential Financial Inc daily Stock Chart

Peers: MET LNC AIG UNM AFL PFG HIG GL VOYA CNO

| Held by: VTI VOO VO IVV SPY VTV DVY XLF VOE VYM

Index	S&P 500	P/E	10.34	EPS (ttm)	10.00	Insider Own	0.25%	Shs Outstand	347.94M	Perf Week	-0.68%
Market Cap	36.00B	Forward P/E	6.66	EPS next Y	15.54	Insider Trans	154.21%	Shs Float	347.11M	Perf Month	-5.53%
Enterprise Value	-	PEG	1.38	EPS next Q	3.40	Inst Own	62.34%	Short Float	2.25%	Perf Quarter	0.78%
Income	3.54B	P/S	0.59	EPS this Y	0.13%	Inst Trans	0.22%	Short Ratio	4.00	Perf Half Y	-3.44%
Sales	60.77B	P/B	1.11	EPS next Y	7.56%	ROA	0.47%	Short Interest	7.83M	Perf YTD	-8.36%
Book/sh	93.23	P/C	-	EPS next 5Y	4.83%	ROE	11.86%	52W High	119.76 -13.63%	Perf Year	-6.92%
Cash/sh	-	P/FCF	5.74	EPS past 3/5Y	- -	ROIC	6.51%	52W Low	90.38 14.45%	Perf 3Y	1.88%
Dividend Est.	5.60 (5.42%)	EV/EBITDA	-	Sales past 3/5Y	2.23% 1.28%	Gross Margin	-	Volatility	2.21% 2.49%	Perf 5Y	23.00%
Dividend TTM	5.45 (5.27%)	EV/Sales	-	EPS Y/Y TTM	33.89%	Oper. Margin	7.66%	ATR (14)	2.66	Perf 10Y	58.26%
Dividend Ex-Date	Feb 17, 2026	Quick Ratio	-	Sales Y/Y TTM	-13.68%	Profit Margin	5.82%	RSI (14)	41.67	Recom	3.05
Dividend Gr. 3/5Y	4.00% 4.18%	Current Ratio	2.14	EPS Q/Q	1718.40%	SMA20	-1.94%	Beta	0.96	Target Price	114.31
Payout	54.03%	Debt/Eq	1.02	Sales Q/Q	25.29%	SMA50	-6.94%	Rel Volume	1.67	Prev Close	102.71
Employees	36824	LT Debt/Eq	0.67	Earnings	Feb 03 AMC	SMA200	-2.89%	Avg Volume	1.96M	Price	103.44
IPO	Dec 13, 2001	Option/Short	Yes / Yes	EPS/Sales Surpr.	-2.10% -1.02%	Trades		Volume	3,269,912	Change	0.71%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-16-25	Initiated	Mizuho	Neutral
Sep-16-25	Initiated	Wolfe Research	Peer Perform
Jan-23-25	Initiated	BMO Capital Markets	Underperform	$101
Nov-14-24	Upgrade	Evercore ISI	Underperform → In-line	$117 → $140
Oct-09-24	Initiated	TD Cowen	Hold	$130
Sep-05-24	Initiated	Barclays	Equal Weight	$118
Aug-12-24	Upgrade	Wells Fargo	Underweight → Equal Weight	$113
May-22-24	Upgrade	Jefferies	Hold → Buy	$121 → $143
Feb-09-24	Downgrade	Raymond James	Strong Buy → Mkt Perform
Jan-03-24	Downgrade	JP Morgan	Overweight → Neutral	$119 → $118
Oct-05-23	Initiated	Deutsche Bank	Hold	$99
Sep-14-23	Upgrade	Jefferies	Underperform → Hold	$70 → $93
Aug-24-23	Upgrade	Raymond James	Mkt Perform → Strong Buy	$125
Apr-04-23	Upgrade	JP Morgan	Neutral → Overweight	$114
Jan-09-23	Downgrade	Goldman	Neutral → Sell	$98 → $96
Dec-16-22	Downgrade	Wells Fargo	Equal Weight → Underweight	$101
Nov-23-22	Downgrade	Raymond James	Strong Buy → Mkt Perform
Sep-22-22	Initiated	Raymond James	Strong Buy	$115
May-24-22	Initiated	Citigroup	Neutral	$100
Mar-25-22	Downgrade	Credit Suisse	Outperform → Neutral	$131 → $121

Show Previous Ratings

Feb-18-26 11:45AM	Are You Looking for a High-Growth Dividend Stock? (Zacks)
Feb-17-26 09:43AM	Prudential Financial Lags Industry, Trades at a Discount: Time to Hold? (Zacks)
06:00AM	Marivic Dar honored as a Luminaries with Heart recipient at the ThinkAdvisor 2025 Luminaries Awards (PR Newswire)
03:27AM	Prudential Financial Stock: Is Wall Street Bullish or Bearish? (Barchart)
Feb-11-26 07:30AM	Montana Capital Partners announces final close of MCP Opportunity Secondary Program VI (OSP VI) (Business Wire)
08:35AM	Loading…
Feb-10-26 08:35AM	Prudential Financial Elects Maryann Mannen to Board of Directors (Business Wire)
12:35AM	The Top 5 Analyst Questions From Prudential's Q4 Earnings Call (StockStory)
Feb-06-26 02:39PM	AM Best Affirms Credit Ratings of Prudential Financial, Inc. and Its Life/Health Subsidiaries (Business Wire)
Feb-05-26 07:44AM	MKL Q4 Earnings Beat Estimates, Revenues & Premiums Rise Y/Y (Zacks)
04:06AM	Prudential Financial Q4 Earnings Call Highlights (MarketBeat)
03:46AM	Company News for Feb 5, 2026 (Zacks)
Feb-04-26 06:01PM	Prudential Financial Inc (PRU) Q4 2025 Earnings Call Highlights: Strong Financial Performance ... (GuruFocus.com)
02:50PM	PRU Q4 Deep Dive: Japan Sales Suspension and Asset Management Outflows Shape Outlook (StockStory)
09:40AM	Why Prudential (PRU) is a Top Value Stock for the Long-Term (Zacks)
09:13AM	Prudential Financial Q4 Earnings Miss, Revenues Beat, Dividend Raised (Zacks)
07:00PM	Loading…
Feb-03-26 07:00PM	Prudential (PRU) Reports Q4 Earnings: What Key Metrics Have to Say (Zacks)
05:35PM	Prudential (PRU) Lags Q4 Earnings Estimates (Zacks)
05:28PM	Prudential (NYSE:PRU) Reports Q4 CY2025 In Line With Expectations (StockStory)
04:42PM	Prudential: Q4 Earnings Snapshot (Associated Press Finance)
04:18PM	Prudential Financial, Inc. Announces Full Year and Fourth Quarter 2025 Results (Business Wire)
04:13PM	Prudential of Japan Implements Voluntary 90-Day Suspension of New Sales to Address Previously Disclosed Employee Misconduct (Business Wire)
Feb-02-26 10:11AM	Watch These 5 Insurance Stocks for Q4 Earnings: Beat or Miss? (Zacks)
06:52AM	Prudential Financial (PRU) Price Target Raised by $2, 'Hold' Rating Maintained (Insider Monkey)
Feb-01-26 10:04PM	What To Expect From Prudential's (PRU) Q4 Earnings (StockStory)
07:47AM	January jobs data, Alphabet and Amazon earnings, more Warsh fallout: What to watch this week (Yahoo Finance)
Jan-30-26 09:48AM	PRU Gears Up to Report Q4 Earnings: Here's What to Expect (Zacks)
05:34AM	Analyst Report: Prudential plc (Morningstar Research)
Jan-29-26 09:15AM	Curious about Prudential (PRU) Q4 Performance? Explore Wall Street Estimates for Key Metrics (Zacks)
03:43AM	Zacks Industry Outlook Highlights American International, Prudential Financial, Markel, Principal Financial Group and Everest (Zacks)
Jan-28-26 12:22PM	5 Multiline Insurers to Watch Amid Prudent Underwriting and Pricing (Zacks)
10:00AM	Loading…
10:00AM	Equitable Holdings, Inc. (EQH) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Jan-27-26 10:00AM	Prudential (PRU) Earnings Expected to Grow: Should You Buy? (Zacks)
Jan-25-26 09:53AM	Prudential Financial, Inc. (PRU) in Focus as Wells Fargo Outlines Key Themes Across Insurance (Insider Monkey)
Jan-22-26 06:00AM	PURE Property Management and HomeRiver Group Merge, Secure $80 Million in Growth Capital (PR Newswire)
Jan-21-26 09:39PM	Mizuho Raises Prudential (PRU) Target to $126, Keeps Neutral Rating (Insider Monkey)
Jan-20-26 06:00AM	Prudential Advisors Enhances Advisor Leads Program with AI and Data Science (PR Newswire)
Jan-14-26 04:17AM	Analyst Report: Prudential plc (Morningstar Research)
Jan-13-26 08:55AM	Want Better Returns? Don't Ignore These 2 Finance Stocks Set to Beat Earnings (Zacks)
Jan-12-26 06:48AM	Financial Services Roundup: Market Talk (The Wall Street Journal)
Jan-07-26 08:35AM	Prudential Financial, Inc. to Announce Fourth Quarter 2025 Earnings; Schedules Conference Call (Business Wire)
Jan-06-26 12:22PM	Prudential Financial's Q4 2025 Earnings: What to Expect (Barchart)
12:10PM	Will Prudential (PRU) Beat Estimates Again in Its Next Earnings Report? (Zacks)
08:55AM	How to Find Strong Finance Stocks Slated for Positive Earnings Surprises (Zacks)
Jan-05-26 08:54AM	RDN Outperforms Industry, Trades Near 52-Week High: Time to Buy? (Zacks)
Jan-02-26 04:49PM	What is an insurance 'float' & what Fed rates mean for insurers (Yahoo Finance Video)
Dec-31-25 02:26PM	Will the Fed Cut or Pause? These Finance Stocks Can Win Either Way (MarketBeat)
Dec-30-25 12:30PM	PRU Stock Trades at Discount to Industry at 7.62X: Time to Hold? (Zacks)
Dec-24-25 06:50AM	Prudential price target raised to $120 from $110 at Piper Sandler (TipRanks)
Dec-23-25 05:25PM	Prudential (PRU) Starts at Neutral as Mizuho Launches Broad Insurance Coverage (Insider Monkey)
Dec-18-25 08:40AM	Prudential Financial Announces Leadership Alignment (Business Wire)
Dec-15-25 11:15AM	Prudential Launches FlexGuard 2.0 with New Investment Allocation Options to Help Customers Protect Their Life's Work, Furthering Commitment to the Registered Index-Linked Annuity Space (Business Wire)
09:50AM	Why Prudential (PRU) is a Top Momentum Stock for the Long-Term (Zacks)
Dec-14-25 08:49AM	3 Finance Stocks to Buy on Rising 10-Year Treasury Rates (MarketBeat)
Dec-13-25 05:04AM	3 No-Brainer Dividend Stocks to Buy Right Now (Motley Fool)
Dec-12-25 09:40AM	Are You a Value Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Dec-08-25 11:36PM	1 Insurance Stock with Exciting Potential and 2 We Avoid (StockStory)
06:00AM	Prudential Advisors Welcomes Advisor Team from Raymond James with Over $550 Million in Assets (PR Newswire)
Dec-03-25 11:30AM	Why Is CNO (CNO) Down 3% Since Last Earnings Report? (Zacks)
08:30AM	Prudential Financial Announces Matt Armas as Chief Investment Officer (Business Wire)
06:00AM	Prudential Advisors Connect mobile app launches, bringing advisor productivity tools to iOS devices, further enhancing the advisor experience (PR Newswire)
Dec-02-25 10:34PM	Q3 Earnings Highs And Lows: Prudential (NYSE:PRU) Vs The Rest Of The Life Insurance Stocks (StockStory)
09:44PM	Perseus Mining Values Predictive Discovery Around $1.3 Billion in Takeover Bid (The Wall Street Journal)
08:54AM	RDN Near 52-Week High: Time to Add the Stock for Better Returns? (Zacks)
Nov-28-25 04:18PM	PGIM Closed-End Funds Declare Distributions for December 2025, January and February 2026 (Business Wire)
11:30AM	Prudential (PRU) Up 4.7% Since Last Earnings Report: Can It Continue? (Zacks)
Nov-27-25 11:29AM	PRU Stock Trading at Discount to Industry at 7.28X: Time to Hold? (Zacks)
Nov-26-25 04:24PM	Bear Signal Flashing for Struggling Insurance Stock (Schaeffer's Research)
Nov-24-25 09:50AM	Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Nov-21-25 09:40AM	Why This 1 Value Stock Could Be a Great Addition to Your Portfolio (Zacks)
Nov-19-25 06:00AM	Prudential Advisors accelerates momentum in 2025, welcoming experienced financial advisors and expanding its national footprint (PR Newswire)
Nov-18-25 08:05AM	Prismic Life Announces Close of US$1.3B Capital Raise (Business Wire)
Nov-17-25 04:05PM	Prudential Financial Announces Tina Madon as Global Head of Investor Relations (Business Wire)
Nov-14-25 04:15AM	5 Dividend Stocks to Hold for the Next 5 Years (Motley Fool)
Nov-12-25 11:03PM	3 Reasons to Sell PRU and 1 Stock to Buy Instead (StockStory)
Nov-05-25 09:50AM	Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio (Zacks)
Nov-04-25 04:18PM	Prudential Financial Declares Quarterly Dividend on Common Stock (Business Wire)
12:23PM	5 Stocks to Watch From the Prospering Multiline Insurance Industry (Zacks)
09:40AM	Here's Why Prudential (PRU) is a Strong Value Stock (Zacks)
Oct-31-25 10:53AM	Reinsurance Group Q3 Earnings Top Estimates on Solid Investment Income (Zacks)
Oct-30-25 09:10PM	Prudential Financial Inc (PRU) Q3 2025 Earnings Call Highlights: Record Operating Income and ... (GuruFocus.com)
02:35PM	Why Prudential (PRU) Stock Is Trading Up Today (StockStory)
12:51PM	Prudential Financial Q3 Earnings Beat Estimates on Lower Expenses (Zacks)
Oct-29-25 09:50PM	BofA Raises Prudential (PRU) Price Target to $118, Maintains Neutral Rating (Insider Monkey)
06:30PM	Compared to Estimates, Prudential (PRU) Q3 Earnings: A Look at Key Metrics (Zacks)
05:45PM	Prudential (PRU) Surpasses Q3 Earnings and Revenue Estimates (Zacks)
05:20PM	Prudential Financial Profit Climbs From Strong Market (The Wall Street Journal)
04:45PM	Prudential (NYSE:PRU) Surprises With Q3 Sales (StockStory)
04:18PM	Prudential Financial, Inc. Announces Third Quarter 2025 Results (Business Wire)
Oct-28-25 10:25AM	What's in Store for These 3 Insurance Stocks in Q3 Earnings? (Zacks)
Oct-27-25 11:14PM	Prudential (PRU) Reports Q3: Everything You Need To Know Ahead Of Earnings (StockStory)
01:39PM	Americans are facing a retirement paradox here's what you need to know (CNBC TV)
12:06PM	Will Escalating Expenses Affect Virtu Financial's Q3 Earnings? (Zacks)
09:30AM	The Confidence Paradox: 2025 Global Retirement Pulse Survey (Business Wire)
Oct-24-25 10:40AM	Is a Beat in the Cards for Prudential Financial This Earnings Season? (Zacks)
10:23AM	What's in the Cards for Everest Group This Earnings Season? (Zacks)
Oct-23-25 01:26PM	Will A Strong Personal Insurance Unit Aid The Hartford's Q3 Earnings? (Zacks)
Oct-22-25 10:00AM	Prudential (PRU) Earnings Expected to Grow: Should You Buy? (Zacks)
Oct-20-25 11:45AM	Why Prudential (PRU) is a Great Dividend Stock Right Now (Zacks)
10:00AM	Dylan Harper and Prudential Financial Join Forces to Showcase Importance of Planning for Your Future Self (Business Wire)
Oct-17-25 08:50AM	These 2 Finance Stocks Could Beat Earnings: Why They Should Be on Your Radar (Zacks)

Prudential Financial, Inc. engages in the provision of insurance, investment management, and other financial products and services. It operates through the following segments: Prudential Investment Management, Inc. (PGIM), U.S. Businesses, International Businesses, and Corporate and Others. The PGIM segment is involved in the provision of investment management services and solutions related to public fixed income, public equity, real estate debt and equity, private credit and other alternatives, and multi-asset class strategies. The U.S. Businesses segment includes retirement strategies, group insurance, and individual life. The International Businesses segment focuses on investing in existing businesses and assessing acquisition opportunities. The Corporate and Other Operations segment relates to the corporate items and initiatives not allocated to business segments. The company was founded by John Fairfield Dryden in 1875 and is headquartered in Newark, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Stoddard Thomas D	Director	Feb 17 '26	Buy	102.97	250	25,742	250	Feb 18 10:03 AM
Wolk Joseph J	Director	Feb 11 '26	Buy	105.32	400	42,128	400	Feb 12 09:44 AM
Walia Vicki	Executive Vice President	Feb 09 '26	Option Exercise	0.00	770	0	3,931	Feb 11 04:51 PM
Waldeck George P Jr.	Executive Vice President	Feb 09 '26	Option Exercise	0.00	10,924	0	69,836	Feb 11 04:48 PM
SULLIVAN ANDREW F	Chief Executive Officer	Feb 09 '26	Option Exercise	0.00	32,065	0	59,137	Feb 11 04:46 PM
SCHMIDT TIMOTHY L	Senior Vice President	Feb 09 '26	Option Exercise	0.00	10,176	0	21,611	Feb 11 04:43 PM
Lowrey Charles F	Chairman of the Board	Feb 09 '26	Option Exercise	0.00	83,367	0	248,931	Feb 11 04:41 PM
KAPPLER ANN M	EVP and General Counsel	Feb 09 '26	Option Exercise	0.00	17,636	0	39,142	Feb 11 04:38 PM
Frias Yanela	EVP and CFO	Feb 09 '26	Option Exercise	0.00	4,190	0	21,756	Feb 11 04:35 PM
Feeney Caroline	Executive Vice President	Feb 09 '26	Option Exercise	0.00	23,728	0	77,247	Feb 11 04:30 PM
Boyle Robert E	Senior Vice President	Feb 09 '26	Option Exercise	0.00	1,020	0	3,830	Feb 11 04:14 PM
Chappuis Jacques	Executive Vice President	Feb 06 '26	Buy	100.97	1,000	100,970	1,000	Feb 09 04:51 PM
Walia Vicki	Executive Vice President	Jan 31 '26	Option Exercise	0.00	5,033	0	5,033	Feb 03 05:44 PM
PRUDENTIAL INSURANCE CO OF AME	10% Owner	Jan 23 '26	Buy	24.87	1,406,739	34,985,590	7,709,624	Jan 27 04:30 PM
Feeney Caroline	Executive Vice President	Jan 12 '26	Option Exercise	0.00	60,761	0	83,378	Jan 14 10:48 AM
Feeney Caroline	Executive Vice President	Dec 11 '25	Option Exercise	107.67	6,662	717,284	25,449	Dec 15 05:49 PM
Feeney Caroline	Executive Vice President	Dec 11 '25	Sale	116.28	6,555	762,215	22,523	Dec 15 05:49 PM
Feeney Caroline	Officer	Dec 11 '25	Proposed Sale	116.28	6,662	774,657		Dec 11 03:04 PM
SCHMIDT TIMOTHY L	Senior Vice President	Dec 02 '25	Sale	107.69	8,000	861,520	11,535	Dec 02 04:45 PM
SCHMIDT TIMOTHY L	Officer	Dec 02 '25	Proposed Sale	107.69	8,000	861,520		Dec 02 02:56 PM
Lowrey Charles F	Chairman of the Board	Nov 10 '25	Sale	107.39	48,164	5,172,332	165,564	Nov 12 05:00 PM
Lowrey Charles F	Officer	Nov 10 '25	Proposed Sale	106.00	48,164	5,105,384		Nov 10 06:33 PM
Boyle Robert E	Senior Vice President	Aug 31 '25	Option Exercise	0.00	352	0	3,533	Sep 04 02:18 PM
KAPPLER ANN M	EVP and General Counsel	Aug 29 '25	Sale	109.65	4,000	438,600	21,506	Sep 03 02:08 PM
KAPPLER ANN M	Officer	Aug 29 '25	Proposed Sale	109.65	4,000	438,600		Aug 29 01:31 PM
PRUDENTIAL FINANCIAL INC	10% Owner	Aug 21 '25	Buy	10.00	1,500,000	15,000,000	1,500,000	Aug 25 02:19 PM
PRUDENTIAL INSURANCE CO OF AME	10% Owner	Jun 16 '25	Buy	28.64	1,675,978	48,000,000	3,168,461	Jun 18 10:06 AM
SCOVANNER DOUGLAS A	Director	May 13 '25	Option Exercise	0.00	1,321	0	26,290	May 15 05:14 PM
POON CHRISTINE A	Director	May 13 '25	Option Exercise	0.00	1,321	0	12,904	May 15 05:08 PM
CASELLAS GILBERT F	Director	May 13 '25	Option Exercise	0.00	1,321	0	1,821	May 15 04:57 PM
Alziari Lucien	Former Section 16 Insider	May 12 '25	Proposed Sale	107.38	11,250	1,208,000		May 12 03:34 PM
PRUDENTIAL INSURANCE CO OF AME	10% Owner	Mar 26 '25	Buy	24.94	721,732	18,000,000	5,656,908	Mar 28 04:36 PM
PRUDENTIAL INSURANCE CO OF AME	10% Owner	Mar 26 '25	Buy	28.53	1,340,694	38,250,000	1,480,681	Mar 27 02:58 PM
PRUDENTIAL INSURANCE CO OF AME	10% Owner	Mar 25 '25	Buy	28.52	52,595	1,500,000	139,987	Mar 27 02:58 PM
PRUDENTIAL INSURANCE CO OF AME	10% Owner	Mar 12 '25	Buy	28.72	87,047	2,500,000	87,047	Mar 14 04:05 PM
SULLIVAN ANDREW F	Executive Vice President	Mar 12 '25	Sale	105.98	6,000	635,880	27,072	Mar 14 01:36 PM
SULLIVAN ANDREW F	Officer	Mar 12 '25	Proposed Sale	105.98	6,000	635,880		Mar 12 04:30 PM
SULLIVAN ANDREW F	Executive Vice President	Feb 28 '25	Option Exercise	0.00	11,017	0	35,084	Mar 04 02:48 PM
SCHMIDT TIMOTHY L	Senior Vice President	Feb 28 '25	Option Exercise	0.00	4,663	0	20,310	Mar 04 02:44 PM
Lowrey Charles F	Chief Executive Officer	Feb 28 '25	Option Exercise	0.00	30,162	0	219,599	Mar 04 02:41 PM
KAPPLER ANN M	EVP and General Counsel	Feb 28 '25	Option Exercise	0.00	6,370	0	26,662	Mar 04 02:38 PM
Frias Yanela	EVP and CFO	Feb 28 '25	Option Exercise	0.00	2,205	0	17,896	Mar 04 02:35 PM
Feeney Caroline	Executive Vice President	Feb 28 '25	Option Exercise	0.00	8,656	0	23,812	Mar 04 02:30 PM
FALZON ROBERT	EVP and Vice Chairman	Feb 28 '25	Option Exercise	0.00	24,129	0	248,345	Mar 04 02:25 PM
Axel Robert	SVP and Controller	Feb 28 '25	Option Exercise	0.00	1,920	0	11,210	Mar 04 02:20 PM
Alziari Lucien	Executive Vice President	Feb 28 '25	Option Exercise	0.00	6,114	0	55,068	Mar 04 02:15 PM

JNJ

Johnson & Johnson

PRU

Prudential Financial Inc

Upgrade your FINVIZ experience